Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Presentation TCT 2016

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Presenter: Helene Eltchaninoff, Neal S. Kleiman, Axel Linke

November 01, 2016

Presentation TCT 2016

Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

TCT 116: Elective Use of Intra-Aortic Balloon Pump For High-Risk Percutaneous Coronary Intervention For ACS: Meta-Analysis of RCTs

Presenter: Simon R. Dixon, Kirk N. Garratt

October 30, 2016

News Conference News TCT 2015

Experts Say ‘Big Data’ Represents Future of Health Care Research

October 13, 2015

Presentation TCT 2015

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

Presenter: Gary M. Ansel, J. A. Mustapha

October 12, 2015

Presentation TCT 2015

The ILLUMINATE RCT: One-Year Outcomes

Presenter: William A. Gray, Peter A. Schneider, Mahmood K. Razavi

October 12, 2015

Presentation TCT 2015

Other Important TAVR Studies 2: The NOTION All-Comer TAVR RCT

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Lars Sondergaard

October 11, 2015

Presentation TCT 2015

Status Update on Moderate-Risk TAVR RCTs 2: SURTAVI

Presenter: Martin B. Leon, Neil E. Moat, Patrick W. Serruys

October 11, 2015

Presentation TCT 2015

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

Presenter: Martin B. Leon, Neil E. Moat

October 11, 2015

News Conference News TCT 2013

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

November 06, 2013

Presentation TCT 2013

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Presenter: E. Murat Tuzcu

October 30, 2013

Presentation TCT 2013

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

Presenter: Jeffrey Popma

October 30, 2013

Presentation TCT 2013

The EVEREST II Randomized Controlled Trial (RCT): Three Year Outcomes

Presenter: Ted Feldman, Elyse Foster, Mansoor Qureshi, Brian Whisenant, John Williams, Donald Glower, Laura Mauri

January 31, 2013

Advertisement

Cerebral Embolic Protection I: The Sentinel Filter - Design Features and Updates from CLEAN-TAVI, SENTINEL RCT, and Others

Update on RCTs in FMR, and First Report of the COAPT Roll-in Patients

TCT 116: Elective Use of Intra-Aortic Balloon Pump For High-Risk Percutaneous Coronary Intervention For ACS: Meta-Analysis of RCTs

Experts Say ‘Big Data’ Represents Future of Health Care Research

After 2 Failed RCTs: Root-Cause Analysis, Unmet Technical Needs and Opportunities for the Development of Next-Generation DCBs, and Studies

DCB in BTK Intervention: Summary of the Evidence From 2 Failed RCTs IN.PACT DEEP and BIOLUX P-II

The ILLUMINATE RCT: One-Year Outcomes

Other Important TAVR Studies 2: The NOTION All-Comer TAVR RCT

Status Update on Moderate-Risk TAVR RCTs 2: SURTAVI

Status Update on Moderate-Risk TAVR RCTs 1: PARTNER IIA

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

Should Innovative New Device Platforms (Like Bioresorbable Scaffolds) Be Studied Using Global All-Comer "Big Data" Clinical Trials Rather Than Smaller Indication-Focused RCTs?

Regulatory Approval Models for New TAVR "In Class" Devices: Are We Back to the Days of Device vs. Device RCTs?

Regulatory Approval Models for Iterative (Next Version) TAVR Devices: Do We Need RCTS or OPC-Controlled Registries?

The EVEREST II Randomized Controlled Trial (RCT): Three Year Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content